N, Minami S, Dan K: Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 2001;124:392–397.
90Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K: Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000;356:1795–1799.
91Hak Ł, Myśliwska J, Więckiewicz J, Szyndler K, Trzonkowski P, Siebert J, Myśliwski A: NK cell compartment in patients with coronary heart disease. Immun Ageing 2007;4:3.
92Cerwenka A, Lanier LL: Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol 2016;16:112–123.
93Castle SC: Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000;31:578–585.
94van Deursen JM: The role of senescent cells in ageing. Nature 2014;509:439–446.
95Campisi J, Robert L: Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol 2014;39:45–61.
96Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM: Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011;479:232–236.
97Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V: Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 2013; 32: 1971–1977.
98Hazeldine J, Hampson P, Lord JM: Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell 2012; 11: 751–759.
99Mariani E, Mariani AR, Meneghetti A, Tarozzi A, Cocco L, Facchini A: Age-dependent decreases of NK cell phosphoinositide turnover during spontaneous but not Fc-mediated cytolytic activity. Int Immunol 1998; 10: 981–989.
100Myśliwska J, Myśliwski A, Witkowski J: Age-dependent decline of natural killer and antibody-dependent cell mediated cytotoxicity activity of human lymphocytes is connected with decrease of their acid phosphatase activity. Mech Ageing Dev 1985;31:1–11.
101Myśliwska J, Bigda J, Myśliwski A: Activity of acid phosphatase in target binding cells expressing NK cytotoxic potential. Acta Histochem 1987;82:127–131.
102McVicar DW, Burshtyn DN: Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Sci STKE 2001;2001:re1.
103Fülöp T, Larbi A, Witkowski JM: Human Inflammaging. Gerontology 2019;65:495–504.
104Fulop T, Witkowski JM, Olivieri F, Larbi A: The integration of inflammaging in age-related diseases. Semin Immunol 2018;40:17–35.
105Fülöp T, Larbi A, Pawelec G: Human T cell aging and the impact of persistent viral infections. Front Immunol 2013;4:271.
106Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu YL, et al: New advances in CMV and immunosenescence. Exp Gerontol 2014;55:54–62.
107Monsiváis-Urenda A, Noyola-Cherpitel D, Hernández-Salinas A, García-Sepúlveda C, Romo N, Baranda L, López-Botet M, González-Amaro R: Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 2010;40:1418–1427.
108Zhang T, Scott JM, Hwang I, Kim S: Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J Immunol 2013;190:1402–1406.
109Béziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Björklund AT, Retière C, Sverremark-Ekström E, Traherne J, Ljungman P, Schaffer M, Price DA, Trowsdale J, Michaëlsson J, Ljunggren HG, Malmberg KJ: NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013;121:2678–2688.
110Luetke-Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, Hamann A, Walter J, Chang HD, Dong J, Romagnani C: Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog 2014;10:e1004441.
111Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, Han H, Chiang SC, Foley B, Mattsson K, Larsson S, Schaffer M, Malmberg KJ, Ljunggren HG, Miller JS, Bryceson YT: Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015;42:443–456.
112Müller-Durovic B, Grählert J, Devine OP, Akbar AN, Hess C: CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany, NY) 2019;11:724–740.
113Wu Z, Sinzger C, Frascaroli G, Reichel J, Bayer C, Wang L, Schirmbeck R, Mertens T: Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J Virol 2013;87:7717–7725.
114Lee J, Zhang T, Hwang I, Kim A, Nitschke L, Kim M, Scott JM, Kamimura Y, Lanier LL, Kim S: Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 2015;42:431–442.
115Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, Oei VYS, Schaffer M, Taskén K, Ljunggren HG, Romagnani C, Trowsdale J, Malmberg KJ, Béziat V: Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans. Cell Rep 2016;15:1088–1099.
116Rölle A, Halenius A, Ewen EM, Cerwenka A, Hengel H, Momburg F: CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol 2016;46:2420–2425.
117Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, Han H, Chiang SC, Foley B, Mattsson K, Larsson S, Schaffer M, Malmberg KJ, Ljunggren HG, Miller JS, Bryceson YT: Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015;42:443–456.
118Makwana